Effects of Ca2+ antagonists on motor activity and the dopaminergic system in aged mice

Neurobiology of Aging

Volumn 24, Issue 2, 2003, Pages 315-319

  Kurosaki, Rumiko ^a   Akasaka, Megumi ^a   Michimata, Mari ^a   Matsubara, Mitsunobu ^a   Imai, Yutaka ^a   Araki, Tsutomu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Behavior; Dopaminergic system; Mice; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMLODIPINE; CALCIUM ANTAGONIST; DOPAMINE; HOMOVANILLIC ACID; NILVADIPINE; CALCIUM CHANNEL BLOCKING AGENT; DRUG DERIVATIVE; NIFEDIPINE;

AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; ANIMAL; ANIMAL BEHAVIOR; BRAIN LEVEL; C57BL MOUSE; MALE; METABOLISM;

3,4-DIHYDROXYPHENYLACETIC ACID; AGING; AMLODIPINE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CALCIUM CHANNEL BLOCKERS; CORPUS STRIATUM; DOPAMINE; HOMOVANILLIC ACID; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NIFEDIPINE;

EID: 0037332317     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00085-4     Document Type: Article

References (24)

1. Araki T., Mizutani H., Matsubara M., Imai Y., Mizugaki M., Itoyama Y. Nitric oxide synthase inhibitors cause motor deficits in mice. Eur. Neuropsychopharmacol. 11:2001;125-133.
2. Araki T., Kumagai T., Tanaka K., Matsubara M., Kato H., Itoyama Y.et al. Neuroprotective effect of riluzole in MPTP-treated mice. Brain Res. 18:2001;176-181.
3. Bannon M.J., Poosch M.S., Xia Y., Goebel D.J., Cassin B., Kapatos G. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7095-7099.
4. Bennett D.A., Beckett L.A., Murray A.M., Shannon C.G., Goetz D.M., Pilgrim D.M.et al. Prevalence of Parkinsonian signs and associated mortality in a community population of older people. N. Eng. J. Med. 34:1996;71-76.
5. Cranasac H., Peyrin L., Cottet-Emard J.M., Farhat F., Pequignot J.M., Reber A. Aging effects on monoamines in rat medial vestibular and cochlear nuclei. Hear Res. 100:1996;150-156.
6. Delion S., Chalon S., Guilloteau D., Besnard J.C., Durand G. α-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotnergic neurotransmission in the rat frontal cortex. J. Neurochem. 66:1996;1582-1591.
7. de Keyser J., Ebinger G., Vauquelin G. Age-related changes in the human nigrostriatal dopaminergic system. Ann. Neurol. 27:1990;157-161.
8. Dorce V.A.C., Palermo-Neto J. Behavioral and neurochemical changes induced by aging in dopaminergic systems of male and female rats. Physiol. Behav. 56:1994;1015-1019.
9. Finch C.E. Catecholamine metabolism in the brains of ageing male mice. Brain Res. 52:1973;261-276.
10. Greenwood C.E., Tatton W.G., Seniuk N.A., Biddle F.G. Increased dopamine synthesis in aging substantia nigra neurons. Neurobiol. Aging. 12:1991;557-565.
11. Kobayashi T., Araki T., Itoyama Y., Takeshiata M., Ohta M., Ohshima Y. Effect of L-DOPA and bromocriptine on haloperidol-induced motor deficits in mice. Life Sci. 61:1997;2529-2538.
12. Konradi C., Kornhuber J., Sofic E., Heckers S., Riederer P., Beckmann H. Variations of monoamines and their metabolites in the human brain putamen. Brain Res. 579:1992;285-290.
13. Kuwaki T., Satoh H., Ohno T., Shibayama F., Yamashita T., Nishimura T. Nilvadipine attenuates ischemic degradation of gerbil brain cytoskeletal proteins. Stroke. 20:1989;78-83.
14. Ma S.Y., Ciliax B.J., Stebbins G., Jaffar S., Joyce J.N., Cochran E.J. Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra. J. Comp. Neurol. 409:1999;25-37.
15. Míguez J.M., Aldegunde M., Paz-Valiñas J., Recio J., Sánchez-Barceleó E. Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging. J. Neural. Transm. 106:1999;1089-1098.
16. Mortimer J.A. Human motor behavior and aging. Ann. N.Y. Acad. Sci. 515:1986;54-66.
17. Ogawa N., Mizukawa K., Hirose K., Kajita S., Ohara S., Watanabe Y. MPTP-induced Parkinsonian model in mice: biochemistry, pharmacology and behavior. Eur. Neurol. 26:1987;16-23.
18. Takakura S., Sogabe K., Satoh H., Mori J., Fujiwara T., Totsuka Z.et al. Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia: a comparative study with nicardipine hydrochloride. Neuosci. Lett. 141:1992;199-202.
19. Takakura S., Furuichi Y., Yamamoto T., Ogawa T., Satoh H., Mori J. Effects of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats. Stroke. 25:1994;677-683.
20. Tatton W.G., Greenwood C.E., Sato P.T., Seniuk N.A. Transmitter synthesis increases in substantia nigra neurons of the aged mouse. Neurosci. Lett. 131:1991;179-182.
21. Tokuma Y., Fujiwara T., Noguchi H. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica. 17:1987;1341-1349.
22. Venero J.L., Machado A., Cano J. Age effects on monoamine turnover of the rat substantia nigra. Brain Res. 557:1991;109-114.
23. Venero J.I., de la Roza C., Machado A., Cano J. Age-related changes on monoamione turnover in hippocampus of rats. Brain Res. 631:1993;89-96.
24. Volkow N.D., Fowler J.S., Wang G.J., Logan J., Schlyer D., MacGregor R.et al. Decreased dopamine transporters with age in healthy human subjected. Ann. Neurol. 36:1994;237-239.